Genome-wide association study of patient and clinician rated global impression severity during antipsychotic treatment

Abstract

Examine the unique and congruent findings between multiple raters in a genome-wide association studies (GWAS) in the context of understanding individual differences in treatment response during antipsychotic therapy for schizophrenia